Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

TCRXTCRX
6 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in TSCAN THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC holds 1M shares of TCRX (TSCAN THERAPEUTICS INC), worth $1M as of 2026-Q2. The position was increased (+29.9% shares). TCRX represents 0.0% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$1M

Current Shares

1M

Total Value Change

+$513,784

Total Shares Change

+946,366

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+29.9%
$1M0.0%$0.98
32
2026-Q1
Increased
808,356
+329.6%
$816,4400.0%$1.03
40
2025-Q4
New
188,152
-
$188,1520.0%$1.03
31
2025-Q1
Exited
0
-100.0%
$00.0%$1.35
0
2024-Q4
Decreased
18,951
-81.7%
$57,6110.0%$3.00
0
2024-Q3
New
103,440
-
$515,1310.0%$5.04
33

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used